Molimard, Julie http://orcid.org/0000-0001-8715-3170
Pajot, Christine
Olle, Priscille
Belot, Alexandre http://orcid.org/0000-0003-4902-5332
Quartier, Pierre http://orcid.org/0000-0002-1769-549X
Uettwiller, Florence
Couret, ChloƩ
Coste, Valentine
Costet, Camille
Bodaghi, Bahram http://orcid.org/0000-0002-0962-5301
Dureau, Pascal
Bailhache, Marion http://orcid.org/0000-0002-0970-1677
Pillet, Pascal
Article History
Received: 8 June 2021
Accepted: 6 August 2021
First Online: 3 September 2021
Declarations
:
: This study was authorised by the Data Protection Officer of our hospital. As an observational multicentric study using pre-existing data, patients and their parents were individually informed in writing to ensure their non opposition. Formal IRB was not required according to the legislation in our country.
: Not applicable.
: P. Quartier received consultancy or speaking fees from AbbVie, Bristol-Myers Squibb, Chugai-Roche, Lilly, Novartis, Novimmune, and Swedish Orphan Biovitrum; and participated in a data safety monitoring board for Sanofi.C. Pajot received consultancy or speaking fees from AbbVie.